These are exciting times in peptide development and clinical translation to life changing results! A study published in The New England Journal of Medicine found that using the type 2 diabetes and weight loss drug semaglutide was linked with improved pain scores in those with osteoarthritis, a painful and degenerative condition affecting the joints
Nausea, fatigue, and headaches are the most common
Researchers should carefully evaluate the remaining evidence base in light of these developments
Importantly, maintaining weight during a plateau is still a clinical winit prevents the typical regain that occurs when people stop treatment or reduce medication dose prematurely
Orlistat (Alli / Xenical): Blocks fat absorption in the digestive system, but can cause unpleasant gastrointestinal side effects
is supported by NIH research grants R01MD014712, U2CDK114886, UL1TR002319, U54DK083912, U01DK100846, OT2HL161847, UM1AI109568, OT2OD032581 and CDC project numbers 75D301-21-P-12254 and 75D301-23-C-18264